Corpath Grx

Corindus Vascular Robotics CorPath GRX robotic vascular intervention system.

CorPath GRX is recorded at the commercial stage, but DEPLOY has no deployment verified at a named site yet; vendor deployment claims are not independently confirmed here. Manufacturer capability claims should be read as claims pending independent verification.

CorPath GRX is made by Corindus Vascular Robotics, based in USA.

CorPath GRX is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

On the DEPLOY registry, comparable surgical robots to CorPath GRX include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.

CorPath GRX and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. CorPath GRX has 0 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

CorPath GRX is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

No verified deployments of CorPath GRX are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.

CorPath GRX has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.